{"success":true,"data":{"pressRelease":{"id":"40390","rtpr_id":"nPn7n6rnha","ticker":"INMD","exchange":"NASDAQ","all_tickers":["INMD"],"title":"InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer","author":"PR Newswire","published_at":"2026-05-20T11:00:02.017Z","article_body":"InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer\n\nPR Newswire\n\nYOKNEAM, Israel, May 20, 2026\n\nYOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD)\n(\"InMode\" or the \"Company\"), a leading global provider of innovative medical\ntechnologies, today announced the appointment of Dr. Shlomo Nass as Chairman\nof the Company's Board of Directors (the \"Board\") and Moshik Itzkovich as\nChief Financial Officer, effective immediately.\n\n(https://mma.prnewswire.com/media/1064477/InMode_Logo.html)\n\nDr. Nass succeeds Dr. Michael Anghel, who retired earlier this month, and will\nlead the Board in supporting the Company's long-term strategic growth and\ngovernance priorities. Dr. Nass brings decades of expertise in corporate law,\naccounting, governance, and audit oversight, with extensive experience\nadvising public and private companies on complex regulatory and financial\nmatters.\n\n\"We are pleased to welcome Shlomo as Chairman of the Board,\" said Moshe\nMizrahy, Chief Executive Officer. \"His deep expertise in corporate governance,\nfinancial oversight, and regulatory matters, combined with his extensive\nleadership experience, will be invaluable as we continue to execute our\nstrategic priorities and drive long-term shareholder value.\"\n\n\"On behalf of the Board and management team, we thank Michael Anghel for his\nmany years of commitment and service to InMode and wish him all the best going\nforward,\" Mizrahy concluded.\n\nAt the same time, InMode announced the appointment of Moshik Itzkovich as\nChief Financial Officer. Moshik has held senior finance roles at InMode and\nwas previously Senior Vice President of Finance. He replaces Yair Malca, who\nstepped down earlier this month and will serve as a consultant at least\nthrough the Company's Annual General Meeting to ensure a smooth transition.\n\n\"Having partnered closely with Yair over the last three years, Moshik brings\ncontinuity, financial expertise, and strategic insight to this role,\" said\nMoshe Mizrahy, Chief Executive Officer. \"We are confident he is well\npositioned to build on our strong financial foundation and support the\nCompany's long-term objectives.\"\n\n\"We thank Yair for his many years of exceptional service. His leadership and\ncontributions have been instrumental to our success, and he played a key role\nin our transition to a publicly traded Company. He leaves InMode with a very\nstrong balance sheet and solid operational and financial foundations in place\nfor his successor. We are grateful for his lasting impact on the Company,\"\nMizrahy concluded.\n\nAbout InMode\n\nInMode is a leading global provider of innovative medical technologies. InMode\ndevelops, manufactures, and markets devices harnessing novel radiofrequency\n(\"RF\") technology. InMode strives to enable new emerging surgical procedures\nas well as improve existing treatments. InMode has leveraged its medically\naccepted minimally invasive RF technologies to offer a comprehensive line of\nproducts across several categories for plastic surgery, gynecology,\ndermatology, otolaryngology, and ophthalmology. For more information about\nInMode and its wide array of medical technologies, visit www.inmodemd.com\n(http://www.inmodemd.com/) .\n\nForward-Looking Statements\n\nThe information in this press release includes forward-looking statements\nwithin the meaning of the federal securities laws. These statements generally\nrelate to future events or InMode's future financial or operating performance,\nincluding the actual amount of share repurchases made by the Company, if any.\nActual outcomes and results may differ materially from what is expressed or\nforecast in such forward-looking statements. In some cases, you can identify\nthese statements because they contain words such as \"anticipate,\" \"believe,\"\n\"estimate,\" \"expect,\" \"intend,\" \"may,\" \"plan,\" \"predict,\" \"project,\" \"will,\"\n\"would\" and similar expressions that concern our expectations, strategic plans\nor intentions. Forward-looking statements are based on management's current\nexpectations and assumptions, and are subject to inherent uncertainties, risks\nand changes in circumstances that are difficult to predict. Consequently,\nactual results could differ materially from those indicated in these\nforward-looking statements. When considering these forward-looking statements,\nyou should keep in mind the risk factors and other cautionary statements\nincluded in InMode's Annual Report on Form 20-F filed with the Securities and\nExchange Commission on February 10, 2026, and our subsequent public filings.\nInMode undertakes no obligation and does not intend to update these\nforward-looking statements to reflect events or circumstances occurring after\nthis press release. You are cautioned not to place undue reliance on these\nforward-looking statements, which pertain only as of the date of this press\nrelease.\n\nInvestor Relations Contact:\n\nMiri Segal-Scharia\nMS-IR LLC\nir@inmodemd.com (mailto:ir@inmodemd.com)\n\nLogo - https://mma.prnewswire.com/media/1064477/5978883/InMode_Logo.jpg\n(https://mma.prnewswire.com/media/1064477/5978883/InMode_Logo.jpg)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/inmode-appoints-dr-shlomo-nass-as-chairman-of-the-board-and-moshik-itzkovich-as-chief-financial-officer-302776826.html\n(https://www.prnewswire.com/news-releases/inmode-appoints-dr-shlomo-nass-as-chairman-of-the-board-and-moshik-itzkovich-as-chief-financial-officer-302776826.html)\n\nSOURCE InMode LTD\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/1064477/InMode_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn7n6rnha","title":"InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer","author":"PR Newswire","ticker":"INMD","created":"2026-05-20T11:00:02.017Z","tickers":["INMD"],"exchange":"NASDAQ","article_body":"InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer\n\nPR Newswire\n\nYOKNEAM, Israel, May 20, 2026\n\nYOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD)\n(\"InMode\" or the \"Company\"), a leading global provider of innovative medical\ntechnologies, today announced the appointment of Dr. Shlomo Nass as Chairman\nof the Company's Board of Directors (the \"Board\") and Moshik Itzkovich as\nChief Financial Officer, effective immediately.\n\n(https://mma.prnewswire.com/media/1064477/InMode_Logo.html)\n\nDr. Nass succeeds Dr. Michael Anghel, who retired earlier this month, and will\nlead the Board in supporting the Company's long-term strategic growth and\ngovernance priorities. Dr. Nass brings decades of expertise in corporate law,\naccounting, governance, and audit oversight, with extensive experience\nadvising public and private companies on complex regulatory and financial\nmatters.\n\n\"We are pleased to welcome Shlomo as Chairman of the Board,\" said Moshe\nMizrahy, Chief Executive Officer. \"His deep expertise in corporate governance,\nfinancial oversight, and regulatory matters, combined with his extensive\nleadership experience, will be invaluable as we continue to execute our\nstrategic priorities and drive long-term shareholder value.\"\n\n\"On behalf of the Board and management team, we thank Michael Anghel for his\nmany years of commitment and service to InMode and wish him all the best going\nforward,\" Mizrahy concluded.\n\nAt the same time, InMode announced the appointment of Moshik Itzkovich as\nChief Financial Officer. Moshik has held senior finance roles at InMode and\nwas previously Senior Vice President of Finance. He replaces Yair Malca, who\nstepped down earlier this month and will serve as a consultant at least\nthrough the Company's Annual General Meeting to ensure a smooth transition.\n\n\"Having partnered closely with Yair over the last three years, Moshik brings\ncontinuity, financial expertise, and strategic insight to this role,\" said\nMoshe Mizrahy, Chief Executive Officer. \"We are confident he is well\npositioned to build on our strong financial foundation and support the\nCompany's long-term objectives.\"\n\n\"We thank Yair for his many years of exceptional service. His leadership and\ncontributions have been instrumental to our success, and he played a key role\nin our transition to a publicly traded Company. He leaves InMode with a very\nstrong balance sheet and solid operational and financial foundations in place\nfor his successor. We are grateful for his lasting impact on the Company,\"\nMizrahy concluded.\n\nAbout InMode\n\nInMode is a leading global provider of innovative medical technologies. InMode\ndevelops, manufactures, and markets devices harnessing novel radiofrequency\n(\"RF\") technology. InMode strives to enable new emerging surgical procedures\nas well as improve existing treatments. InMode has leveraged its medically\naccepted minimally invasive RF technologies to offer a comprehensive line of\nproducts across several categories for plastic surgery, gynecology,\ndermatology, otolaryngology, and ophthalmology. For more information about\nInMode and its wide array of medical technologies, visit www.inmodemd.com\n(http://www.inmodemd.com/) .\n\nForward-Looking Statements\n\nThe information in this press release includes forward-looking statements\nwithin the meaning of the federal securities laws. These statements generally\nrelate to future events or InMode's future financial or operating performance,\nincluding the actual amount of share repurchases made by the Company, if any.\nActual outcomes and results may differ materially from what is expressed or\nforecast in such forward-looking statements. In some cases, you can identify\nthese statements because they contain words such as \"anticipate,\" \"believe,\"\n\"estimate,\" \"expect,\" \"intend,\" \"may,\" \"plan,\" \"predict,\" \"project,\" \"will,\"\n\"would\" and similar expressions that concern our expectations, strategic plans\nor intentions. Forward-looking statements are based on management's current\nexpectations and assumptions, and are subject to inherent uncertainties, risks\nand changes in circumstances that are difficult to predict. Consequently,\nactual results could differ materially from those indicated in these\nforward-looking statements. When considering these forward-looking statements,\nyou should keep in mind the risk factors and other cautionary statements\nincluded in InMode's Annual Report on Form 20-F filed with the Securities and\nExchange Commission on February 10, 2026, and our subsequent public filings.\nInMode undertakes no obligation and does not intend to update these\nforward-looking statements to reflect events or circumstances occurring after\nthis press release. You are cautioned not to place undue reliance on these\nforward-looking statements, which pertain only as of the date of this press\nrelease.\n\nInvestor Relations Contact:\n\nMiri Segal-Scharia\nMS-IR LLC\nir@inmodemd.com (mailto:ir@inmodemd.com)\n\nLogo - https://mma.prnewswire.com/media/1064477/5978883/InMode_Logo.jpg\n(https://mma.prnewswire.com/media/1064477/5978883/InMode_Logo.jpg)\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/inmode-appoints-dr-shlomo-nass-as-chairman-of-the-board-and-moshik-itzkovich-as-chief-financial-officer-302776826.html\n(https://www.prnewswire.com/news-releases/inmode-appoints-dr-shlomo-nass-as-chairman-of-the-board-and-moshik-itzkovich-as-chief-financial-officer-302776826.html)\n\nSOURCE InMode LTD\n\n\n\nPhoto: \nhttps://mma.prnewswire.com/media/1064477/InMode_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-05-20T11:00:02.040961369Z","server_sent_at_ms":1779274802040},"received_at":"2026-05-20T11:00:02.311Z","source_url":"https://www.prnewswire.com/news-releases/inmode-appoints-dr-shlomo-nass-as-chairman-of-the-board-and-moshik-itzkovich-as-chief-financial-officer-302776826.html"},"analysis":{"id":"29828","press_release_id":"40390","analysis_json":{"industry":{"label":"Medical Devices","sector":"Health Care"},"redFlags":[],"eventType":"executive_change","narrative":"InMode appointed Dr. Shlomo Nass as Chairman of the Board, succeeding Dr. Michael Anghel who retired earlier this month.\n\nNass brings decades of expertise in corporate law, accounting, and governance to lead the Board’s oversight of strategic growth.\n\nSimultaneously, InMode promoted Moshik Itzkovich from Senior Vice President of Finance to Chief Financial Officer, replacing Yair Malca who stepped down to serve as a consultant through the AGM.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Orderly leadership transition at InMode with internal CFO promotion and experienced new Chairman."},"keyFigures":{},"quotedText":"His deep expertise in corporate governance, financial oversight, and regulatory matters, combined with his extensive leadership experience, will be invaluable as we continue to execute our strategic priorities and drive long-term shareholder value.","namedEntities":{"people":[{"name":"Dr. Shlomo Nass","role":"Chairman of the Board"},{"name":"Moshik Itzkovich","role":"Chief Financial Officer"},{"name":"Dr. Michael Anghel","role":"Former Chairman"},{"name":"Yair Malca","role":"Former CFO"},{"name":"Moshe Mizrahy","role":"Chief Executive Officer"},{"name":"Miri Segal-Scharia","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"InMode Ltd.","ticker":"INMD","relationship":"filer"},{"name":"MS-IR LLC","relationship":"investor relations firm"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine succession of a retiring Chairman and an outgoing CFO with an internal promotion. No surprise departures or governance red flags; the transitions are orderly and planned."},"tickerRelevance":{"others":[],"primary":"INMD"},"globalImportance":25,"audienceRelevance":30,"eventTypeSecondary":["board_change"],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"routine_succession","sectorWeight":"healthcare_devices","householdBrandBoost":0,"marketCapAdjustment":0}},"event_type":"executive_change","event_type_secondary":["board_change"],"sentiment":"neutral","material_impact_score":2,"narrative":"InMode appointed Dr. Shlomo Nass as Chairman of the Board, succeeding Dr. Michael Anghel who retired earlier this month.\n\nNass brings decades of expertise in corporate law, accounting, and governance to lead the Board’s oversight of strategic growth.\n\nSimultaneously, InMode promoted Moshik Itzkovich from Senior Vice President of Finance to Chief Financial Officer, replacing Yair Malca who stepped down to serve as a consultant through the AGM.","key_figures":{},"named_entities":{"people":[{"name":"Dr. Shlomo Nass","role":"Chairman of the Board"},{"name":"Moshik Itzkovich","role":"Chief Financial Officer"},{"name":"Dr. Michael Anghel","role":"Former Chairman"},{"name":"Yair Malca","role":"Former CFO"},{"name":"Moshe Mizrahy","role":"Chief Executive Officer"},{"name":"Miri Segal-Scharia","role":"Investor Relations Contact"}],"products":[],"companies":[{"name":"InMode Ltd.","ticker":"INMD","relationship":"filer"},{"name":"MS-IR LLC","relationship":"investor relations firm"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-20T11:03:33.830Z","global_importance":25,"audience_relevance":30,"importance_components":{"tickerTier":"mid-cap","eventGravity":"routine_succession","sectorWeight":"healthcare_devices","householdBrandBoost":0,"marketCapAdjustment":0}},"durationMs":21067,"modelName":"george-droid-qwen-72b"}}